Influenza Virus Vaccines and Vaccination
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Influenza Virus Vaccines".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 483
Special Issue Editor
Interests: epidemiology and prevention of infectious diseases (with a focus on influenza, H7N9/H5N1 avian influenza, and COVID-19, as well as viral hepatitis); big data mining in infectious disease research; research in public health models
Special Issue Information
Dear Colleagues,
We are pleased to announce a Special Issue dedicated to the theme "Influenza Virus Vaccines and Vaccination”. We invite researchers and experts from diverse backgrounds to submit high-quality research papers and reviews that explore the immunopathogenic mechanisms and strategies for controlling influenza viruses. We encourage scientists to share their experimental findings and theoretical insights in the form of open-access publications. To ensure the reproducibility of research, we request contributors to provide comprehensive details of their experiments. Additionally, authors are encouraged to include computational data or supplementary materials in their submissions, along with providing complete procedural information.
Through promoting interdisciplinary collaboration and facilitating the dissemination of detailed research outcomes, the primary objective of this Special Issue is to enhance our comprehension of the intricate immunopathogenic mechanisms associated with influenza viruses, while also fostering the development of innovative approaches for the effective management of influenza virus infections.
We look forward to receiving your valuable contributions to this timely and significant Special Issue.
Best regards,
Prof. Dr. Shigui Yang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- influenza virus
- immunopathogenic mechanisms
- prevention and control
- epidemiologic feature
- immune responses to influenza virus
- influenza vaccine development and efficacy evaluation
- influenza vaccine technology
